Analytical Chemistry in the Regulatory Science of Medical Devices

被引:7
|
作者
Wang, Yi [1 ]
Guan, Allan [1 ]
Wickramasekara, Samanthi [1 ]
Phillips, K. Scott [1 ]
机构
[1] US FDA, Div Biol Chem & Mat Sci, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth,Off Med Prod & Tobacco, Silver Spring, MD 20993 USA
关键词
medical device; regulatory science; total product life cycle; analytical chemistry; biomaterials; FDA; CIRCULATING TUMOR-CELLS; STAPHYLOCOCCUS-AUREUS; BACTERIAL BIOFILMS; IN-SITU; DIFFERENTIAL ADHESION; RESISTANCE; HEPARIN; CONTAMINATION; CRIZOTINIB; ENRICHMENT;
D O I
10.1146/annurev-anchem-061417-125556
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In the United States, regulatory science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all Food and Drug Administration-regulated products. Good regulatory science facilitates consumer access to innovative medical devices that are safe and effective throughout the Total Product Life Cycle (TPLC). Because the need to measure things is fundamental to the regulatory science of medical devices, analytical chemistry plays an important role, contributing to medical device technology in two ways: It can be an integral part of an innovative medical device (e.g., diagnostic devices), and it can be used to support medical device development throughout the TPLC. In this review, we focus on analytical chemistry as a tool for the regulatory science of medical devices. We highlight recent progress in companion diagnostics, medical devices on chips for preclinical testing, mass spectrometry for postmarket monitoring, and detection/characterization of bacterial biofilm to prevent infections.
引用
收藏
页码:307 / 327
页数:21
相关论文
共 50 条